Envisia Therapeutics, Inc.

Envisia Therapeutics, Inc.

Envisia Therapeutics, Inc.

Date Founded




Type of Company


Employees (Worldwide)

11 - 50


Hospitals & Patient Services
Medical Support Services
Holding Companies

Company Description

Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC.

Contact Data
Trying to get in touch with decision makers at Envisia Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


Executive Chairman

Clinical Research Director

Vice President-Clinical Operations

Regulatory Affairs Manager

Scientist III

Board of Directors

Chief Executive Officer & Director at ALDEA Pharmaceuticals, Inc.

Paths to Envisia Therapeutics, Inc.
Potential Connections via
Relationship Science
Envisia Therapeutics, Inc.
Recent Transactions
Details Hidden

Envisia Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Envisia Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Wakefield Group invests in companies located in United states. The firm focuses on growth capital investments in companies in the technology, healthcare, business services and media sectors. It provides financing for early stage capital requirements with an investment size in the range of $1 - $5 million per transaction and also provides follow-on capital financing.

Details Hidden

Morningside Group is an active, long-term manager which invests in a range of sectors including telecom and Internet, machinery manufacturing, high-tech, media, telecommunications, life sciences and education sectors. They invets in companies in North America, Europe and Asia Pacific, with a particular focus on China.The firm seeks to create value in their investee companies, partnering with managementto develop strategy, build the necessary management infrastructure, access domestic and international growth opportunities and achieve optimal investment exit through capital market operations.

Details Hidden

New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Envisia Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Envisia Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Envisia Therapeutics, Inc..